Screener
LENZ Therapeutics, Inc. LENZ Q1 2026 earnings
Reported May 11, 2026 · After market close
Revenue$1.9MBeat by $142.1K
EPS-$1.32Miss by $0.22
Revenue estimate$1.8M
EPS estimate-$1.10
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$4.5M
EPS estimate-$1.02
Versus estimates
Revenue
Q2 2026$5.5MBeat by $3.1M
Q1 2026$1.9MBeat by $142.1K
Q4 2025$1.6MMiss by $1.5MQ3 2025$12.5MBeat by $9.5MQ2 2025$5.0MBeat by $4.3MDiluted EPS
FAQ
- When did LENZ Therapeutics, Inc. report Q1 2026 earnings?
- LENZ Therapeutics, Inc. (LENZ) reported Q1 2026 earnings on May 11, 2026 after market close.
- What were LENZ Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- LENZ Therapeutics, Inc. reported revenue of $1.9M and eps of $-1.32 for Q1 2026.
- Did LENZ Therapeutics, Inc. beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $1.8M by $142.1K. EPS missed the consensus estimate of $-1.10 by $0.22.
- How did LENZ Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 149.1% from $-0.53.
- Where can I find LENZ Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001815776-26-000035) and the 10-Q periodic report (0001815776-26-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.
